Facebook Linkedin Pinterest Reddit Twitter
ARTICLES
Less than 1 min.Read

Kolabtree CEO Ashmita Das Interviews Centivax CEO Jacob Glanville

Jacob Glanville

In this interview, Centivax CEO Jacob Glanville speaks with Ashmita Das, CEO of freelancing platform Kolabtree, about COVID-19 vaccine manufacturing, how remote work has impacted research, and the current state of innovation in the biotech industry.

Notably featured in the Netflix documentary Pandemic, Glanville is an immuno-engineer (or an “immune hacker” as he prefers to call himself) and entrepreneur. He developed the core business model and technology for Distributed Bio and its spin-off Centivax, both of which follow a lean business model to minimize redundancy and maximize efficiency, resulting in sustained profits without external investment. Full transcript is available here.

Innovators Speak E01: Kolabtree CEO Ashmita Das interviews Centivax CEO Jacob Glanville

Kolabtree are the experts in providing competent scientific writers and much more.

SourceKolabtree

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330

Exit mobile version